Navigation Links
Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
Date:4/17/2009

CLEVELAND, Ohio, April 17 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products.

Johnson & Johnson LLC, a subsidiary of Johnson & Johnson, operates in Russia, the Ukraine, and other CIS countries.

Johnson & Johnson LLC will have exclusive rights to distribute Simbionix's line of advanced medical simulators in hospitals in Russia and the rest of the CIS.

"We are very excited to enter into this collaboration with Johnson & Johnson LLC to bring our advanced simulators into Russian hospitals, teaching facilities, and interventional clinics," said Simbionix CEO Gary Zamler. "This agreement ushers in a new era of simulation-based interventional training for the CIS medical community and we are looking forward to a mutually beneficial relationship with all the countries covered by the agreement, as well as with Johnson & Johnson LLC."

"In the last year, Simbionix has increased its distribution channels and its presence on the international market," explains Mr. Doron Zilberman, Simbionix's VP of International Sales. "We see Russia as one of the leading markets in the emerging medical world, and our agreement is a sign of Simbionix's success in the international market ..."

About Simbionix

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. Visit
'/>"/>

SOURCE Simbionix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
2. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
3. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
4. Simbionix Launches Innovative Patient-Specific Simulation
5. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
6. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
7. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
8. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
9. Simbionix Increases Product Offerings for OB/GYN Physicians
10. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
11. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, today ... In this role, Michelle will work with current and potential ... development of iLab products. Her main goal will be to ... scientific community by offering the most advanced, user-friendly, and high-impact ...
(Date:1/14/2014)... 2014 Global Record Systems, LLC, ... technology solutions for patients, physicians, the biopharmaceutical industry, ... today the signing of a three-year Research Collaboration ... Administration (FDA). This initiative is designed to ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Continental Airlines CEO Larry Kellner, and the Greater Houston ... April 23 TechConnect World today announced an all-star ... TechConnect World trio of conferences -- which includes ... events, at the George R. Brown Convention Center in ...
... April 23 /PRNewswire-Asia/ -- Lotus Scarless Hair Transplantation,(International) ... their,new flagship transplant center on the prestigious Chang,an ... is the first U.S. specialized,medical and plastics institution ... With a floor area of 1,000 ...
... 22 Three attorneys who previously worked at McKenna ... Atlanta office. The attorneys include Mark S. Lange, partner, ... and Larry A. Slovensky, a partner in ... good lawyers back into the fold," said MLA chairman ...
Cached Biology Technology:TechConnect World Conference Showcases Houston Leaders May 3-7, at the George R. Brown Convention Center 2TechConnect World Conference Showcases Houston Leaders May 3-7, at the George R. Brown Convention Center 3Lotus Scarless Hair Transplantation (International) Medical Chain Institute Opens New Center on Beijing's Prestigious Chang'An Avenue 2Three Attorneys Rejoin McKenna Long & Aldridge 2
(Date:4/17/2014)... cartridge developed at Sandia National Laboratories and recently licensed ... and cheaper. , Bacillus anthracis , the ... all over the world and can cause serious, and ... bacteria can survive in harsh conditions for decades. In ... through skin contact, inhalation of spores or eating contaminated ...
(Date:4/17/2014)... cells in bone marrow need to produce hydrogen sulfide ... according to a new study from the Center for ... Dentistry of USC. , Professor Songtao Shi, principal investigator ... produced by the cells governs the flow of calcium ... signals that results in osteogenesis, or the creation of ...
(Date:4/17/2014)... parasites and pathogens that devastate honeybees in Europe, Asia ... but do not appear to be impacting native honeybee ... of researchers., The invasive pests include including Nosema ... African honeybees appear to be resilient to these invasive ... to control pests in Europe, Asia and the United ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3
... establish a social infrastructure that facilitates successful science-based management ... networks, according to a study from the U.S. Forest ... the studywhich is featured in the January issue of ... stationcan help watershed councils increase the effectiveness of their ...
... are used to assess the intelligence of human beings. ... for bacteria ― and it may lead to new ... industry. An international team led by Prof. Eshel ... Astronomy and his research student Alexandra Sirota-Madi says that ...
... (January 21, 2011) -- The Biophysical Society,s 55th Annual ... Baltimore Convention Center in Baltimore, MD. There, more than ... in understanding and breakthroughs in technology at every level ... organisms, and environments. The Biophysical Society is the ...
Cached Biology News:Immersive data collection, peer networks among key elements of effective watershed councils 2The genius of bacteria 2Upcoming conference: Biophysical Society's 55th Annual Meeting 2
Rabbit polyclonal to Syntrophin alpha 1 ( Abpromise for all tested applications). entrezGeneID: 6640 SwissProtID: Q13424...
Mouse monoclonal [4i97] to HLA Class 1 A25 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 1 Antigen-A25. Swiss Protein ID: P18462...
Mouse Anti-Human MCAF-(MCP-1)...
LTBP-1 (E-20)...
Biology Products: